Table 3.
Expert panel global photographic assessment on vertex and frontal area at weeks 12 and 24 of treatment compared to baseline
| 7-Point rating scalea | 12 weeks, n (%) | 24 weeks, n (%) |
|---|---|---|
| Vertex area | ||
| − 3 | 0 (0) | 0 (0) |
| − 2 | 0 (0) | 0 (0) |
| − 1 | 0 (0) | 0 (0) |
| 0 | 1 (3.3) | 0 (0) |
| + 1 | 7 (23.3) | 2 (6.7) |
| + 2 | 20 (66.7) | 15 (50) |
| + 3 | 2 (6.7) | 13 (43.3) |
| Frontal area | ||
| − 3 | 0 (0) | 0 (0) |
| − 2 | 0 (0) | 0 (0) |
| − 1 | 0 (0) | 0 (0) |
| 0 | 51 (16.7) | 0 (0) |
| + 1 | 11 (36.7) | 8 (26.7) |
| + 2 | 12 (40) | 19 (63.3) |
| + 3 | 2 (6.7) | 3 (10) |
aA standardized 7-point rating scale (− 3 to + 3) was used, in which − 3 indicates greatly decreased; − 2, moderately decreased; − 1, minimally decreased; 0, no change; + 1, minimally increased; + 2, moderately increased; + 3, greatly increased